Hepatotoxicity Screening on In Vitro Models and the Role of 'Omics
| Autor: | Jan Polman, Leo van de Ven, Marja Driessen, Leo S. Price, Sreenivasa Ramaiahgari, Freddy Van Goethem, Geert R. Verheyen, Ewa Szalowska, Karen Mathijs, Maarten L. J. Coonen, Joost H.M. van Delft |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2014 |
| Předmět: |
Phospholipidosis
Liver injury Hepatitis Cirrhosis Cholestasis Steatosis Novel Foods & Agrochains business.industry BU Toxicologie BU Toxicology Hepatotoxicity Pharmacology medicine.disease Bioinformatics Omics Novel Foods & Agroketens Necrosis BU Toxicologie Novel Foods & Agroketens Toxicity medicine In vitro liver models BU Toxicology Novel Foods & Agrochains business |
| Zdroj: | Toxicogenomics-Based Cellular Models Toxicogenomics-Based Cellular Models. Elsevier |
| Popis: | The liver is one of the five most common target organs of toxicity, both during acute and chronic (repeated dose) toxicity, not only for drugs but also for cosmetic ingredients. Chemical entities can trigger liver damage in humans, and hepatotoxicity is the leading cause of withdrawal of drugs from the market, accounting for 40% of withdrawals worldwide. It has been estimated that only 50% of human liver toxicities could be predicted using animal models, and there is a clear need for accurately predictive toxicity and safety testing methods. Hepatocellular injury can manifest in a number of ways, including hepatitis, steatosis, cirrhosis, inflammation, phospholipidosis, and cholestasis. Cholestasis and steatosis are among the most prominent and well-documented types of liver injury and are the focus of this chapter. Furthermore, attention is also paid to necrosis, a mode of cell death that is observed in most of the aforementioned types of hepatocellular injury. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|